New fast test to diagnose bacterial endophthalmitis

Article

A newly-developed fast real-t PCR (f-real-t PCR) test is an effective and much more rapid way to diagnose bacterial endophthalmitis (BE), concluded a study published online ahead of print by the British Journal of Ophthalmology.

A newly-developed fast real-t PCR (f-real-t PCR) test is an effective and much more rapid way to diagnose bacterial endophthalmitis (BE), concluded a study published online ahead of print by the British Journal of Ophthalmology.

Pablo Goldschmidt, of the Laboratoire du Centre National d’Ophtalmologie des Quinze-Vingts, France, and colleagues examined specimens of vitreous fluid (VF) and aqueous humour (AH) cells from endophthalmitis, infected with bacteria or non-infective disorders and control to determine if the f-real-t PCR testing method they had developed could overcome the barriers most commonly associated with BE testing, including insufficient VF or AH, PCR cross-contamination and culture insensitivity, to identify the bacteria and Genera of the DNA that had been extracted from the specimen cells. The team compared the diagnoses with those from direct microscopic examination and culture.

The f-real-t PCR showed no cross-reactivity with fungi even though it detected ≥0.01 CFU Bac/µl and had a 100% correlation with culture positive results. Of the BE samples, 60% tested culture positive; with f-real-t PCR, this was 90%. Within 90 minutes, the f-real-t PCR detected and quantified the presence of Bac, Staphylococci, Streptococci, Haemophilus, Pseudomonas, Enterobacteria, Acinetobacter, Propionbacteriacae and Corynebacteria. The non-infective cells tested negative.

The team therefore concluded that their f-real-t PCR test reduced substantially the hours or even days required for cultures, and provided a more accurate result. The test’s developers now plan to run a larger series of samples to assess the utility of the test.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.